Gestalt, a leader in digital pathology and AI-driven laboratory solutions, is proud to announce that OmniPathology, a high-complexity independent pathology laboratory…

Dr. Ronald Blum, Vice President of Science and Technology at OmniPathology, attended the 2025 Association for Diagnostics & Laboratory Medicine (ADLM) Conference in…

OmniPathology and Delta Labs Announce International Collaboration to Expand Access to Proprietary Oropharyngeal HPV Swab Testing

OmniPathology showcased its latest innovations in gastroenterology-related testing and services at Digestive Disease Week (DDW) 2025, held May 3–6 at the San Diego Convention Center.

Ronald Blum, Ph.D., Vice President of Science & Technology at OmniPathology, is one of the industry experts cited in…

Clinical Lab Products magazine interviewed Ronald A. Blum, Ph.D.,  vice president of science & technology at OmniPathology, for the cover story of its…

As part of its ongoing commitment to public health, OmniPathology offered oropharyngeal human papillomavirus (HPV) testing, educational resources, and life-saving information to attendees at Palm Springs Pride 2024.

On July 19, 2024. Dr. Mohammad Kamal, founder and medical director of OmniPathology, teamed up with Susan Cotten, founder and CEO of Oral Cancer Consulting, to present the “Oral Cancer Screening Workshop: It’s More Than Grasping the Tongue.”

Dr. Mohammad Kamal delivers his inspiring lecture “Oropharyngeal HPV Testing: An Opportunity to Make a Difference” LIVE at CDA’s Art & Science of Dentistry event in Anaheim, CA.

Throat cancer is on the rise. OmniPathology releases important video regarding throat HPV testing.

Healthcare startup announces partnership with private lab to add oral HPV testing to offerings…

OmniPathology, an independent, physician-owned and operated pathology lab, today announced the launch of a new oral test for human…

On February 26, 2021, Dr. Mohammad Kamal, Founder and CEO of OmniPathology gave a zoom seminar to graduate and undergraduate students at…

As schools prepare to reopen, OmniClassroom offers a comprehensive program that allows schools to test staff, students, and families…

Listen to Dr. Mohammad Kamal’s interview on 102.3 FM with Dominique DiPrima regarding testing for COVID-19…

OmniPathology, an independent, physician-owned and operated pathology lab, and Total Testing Solutions (TTS), providers of health testing…

OmniPathology today announced that it has received an FDA Emergency Use Authorization EUA letter for its Omni-COVID-19 Assay polymerase chain…

OmniPathology continues its efforts in offering COVID-19 testing to the community. As companies are getting ready to gradually resume normal schedule and…

OmniPathology today announced the launch of its COVID-19 Lab Developed Test LDT. In response to the US Food and Drug Administration (FDA) policy announcement…

As a one of the nation’s pathology leaders, Dr. Kamal was interviewed by Laboratory Economics for their February 2020 edition. In his interview Dr. Kamal discusses…